首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >Applying radio-frequency identification (RFID) technology in transfusion medicine
【24h】

Applying radio-frequency identification (RFID) technology in transfusion medicine

机译:射频识别(RFID)技术在输血医学中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

ISO/IEC 18000-3 mode 1 standard 13.56 MHz RFID tags have been accepted by the International Society for Blood Transfusion (ISBT) and the United States Food and Drug Administration (FDA) as data carriers to integrate with and augment ISBT 128 barcode data carried on blood products. The use of 13.56 MHz RFID carrying ISBT 128 data structures allows the global deployment and use of RFID, supporting both international transfer of blood and international disaster relief.The deployment in process at the BloodCenter of Wisconsin and testing at the University of Iowa Health Center is the first FDA-permitted implementation of RFID throughout in all phases of blood banking, donation through transfusion. RFID technology and equipment selection will be discussed along with FDA-required RF safety testing; integration with the blood enterprise computing system and required RFID tag performance. Tag design and survivability is an issue due to blood bag centrifugation and irradiation. Deployment issues will be discussed. Use of RFID results in significant return on investment over the use of barcodes in the blood center operations through labor savings and error reduction.
机译:ISO / IEC 18000-3模式1标准13.56 MHz RFID标签已被国际输血协会(ISBT)和美国食品药品监督管理局(FDA)接受为数据载体,以整合并增强所携带的ISBT 128条码数据在血液制品上。使用带有ISBT 128数据结构的13.56 MHz RFID可以在全球范围内部署和使用RFID,同时支持国际血液传输和国际救灾。威斯康星州血液中心正在进行的部署以及爱荷华大学卫生中心的测试是FDA在血液存储的所有阶段(通过输血捐赠)首次实施的RFID许可。将讨论RFID技术和设备的选择以及FDA要求的RF安全测试;与血液企业计​​算系统集成,并具有所需的RFID标签性能。由于血袋离心和辐照,标签设计和生存能力是一个问题。将讨论部署问题。与节省血液和减少错误的血液中心操作中使用条形码相比,RFID的使用产生了可观的投资回报。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号